Ralphey. If the Germans believe reimbursing for Vazkepa will save their health system euros ...they'll reimburse. Questions are 1) Do they believe the R-IT risk reduction is accurate or do they need independent confirming data 2) Do they reimburse for all secondary prevention patients or only those with the lowest NNT ( number needed to treat ) 3) How low can they get AMRN to go on their pricing